Revenue
$7.8m
+29.7% ↑ vs $6m
PBT grew just 1.6% and NPAT growth of 15.8% relied on a lower tax charge as the dominant Finance segment's profitability contracted.
Revenue context before the current result.
Operating cash flow across covered periods.
Statutory profit after tax across covered periods.
Borrowings less cash across covered periods.
Key metrics
HY24 vs HY23
Revenue
$7.8m
+29.7% ↑ vs $6m
Net profit after tax
$0m
Suppressed: metric quality flags mark this value as unsuitable for normal comparison.
Net cash inflow from operating activities
$9.9m
— vs —
Profit before tax
$0m
Suppressed: metric quality flags mark this value as unsuitable for normal comparison.
Cash and cash equivalents
$0.02m
Suppressed: metric quality flags mark this value as unsuitable for normal comparison.
Total assets
$141.5m
+12.0% ↑ vs $126.3m
What changed
Reported NPAT grew 15.8% to $1.2m, with the 14.2pp gap between PBT and NPAT growth explained by a lower effective tax charge in the current period.
The dominant Finance segment, which produced 96.7% of group revenue, saw its segment result fall to $1.2m from $1.5m year-on-year even as its revenue grew roughly 26%. The improvement at group operating level came from the far smaller Research & Advisory segment swinging from a $0.2m loss to a $0.1m profit.
Total assets reached $141.5m (+12%) and total equity rose to $25.4m (+75%), with cash up to $21.5m. Operating cash inflow was $9.9m, but for a lender this reflects loan-book and funding-base movements rather than operating cash conversion.
What matters
Finance segment revenue grew but its result fell from $1.5m to $1.2m, meaning the core lending operation produced less segment profit on a larger base. The headline 29.7% revenue growth therefore did not flow through to the dominant business's profitability, suggesting net interest spreads or impairment costs moved unfavourably.
Tax line drove most of the NPAT growth. PBT grew 1.6% while NPAT grew 15.8% — a 14.2pp gap. Operating performance was roughly flat year-on-year; the apparent bottom-line momentum came from a lower current-period tax charge, not from core profitability improving, and is not necessarily repeatable.
Equity base expanded 75% to $25.4m. Capital growth of this size materially changes per-share economics and forward return on equity. With annualised NPAT of around $2.4m on a $25.4m equity base, indicative ROE compresses versus the prior comparable period despite the reported profit "record."
Expectations
Annualising current H1 figures implies full-year revenue around $15.6m and NPAT around $2.4m. Management commentary describes the remainder of the year as "expected to be strong and profitable with continued balance sheet growth," but this is qualitative; no specific quantitative target is disclosed.
This matters because, against a 75% larger equity base, simply repeating prior-year NPAT scale would represent a meaningful ROE step-down. The release does not provide enough forward detail to judge whether second-half balance-sheet growth will translate into the profit growth needed to defend prior-period returns.
Quality of result
PBT growth of just 1.6% indicates the core business is essentially flat at the operating level once tax dynamics are removed. The dominant Finance segment producing a lower result on higher revenue is the clearer durability concern — this points to either pricing pressure, rising funding costs eroding net interest margin, or higher impairment activity.
Operating cash flow of $9.9m looks strong relative to NPAT, but it should not be read as typical operating cash conversion. For a lender, OCF is dominated by movements in customer loans and funding flows rather than free cash available to shareholders, so the 818.7% FCF-to-NPAT ratio is mechanically inflated. The twice-upgraded credit rating referenced in the release is a positive durability signal but is reported only at a headline level here.
Unresolved
This briefing cannot assess underlying net interest margin, impairment activity, or capital-raise dilution mechanics because the release excerpts and segment disclosures do not separate interest income from funding costs, expense composition, or share-issuance detail.
Chat
Ask follow-up questions about General Capital's HY24 result.
Informational only. No buy, sell, hold, price-target, or personal financial advice.
Informational only. No buy, sell, hold, price-target, or personal financial advice.
Open to load segment breakdown.
Open to load analytical metrics.
Open to load key metrics.
General Capital Announces Another Profit Record
HY24 / results releaseGeneral Capital Half Year Results to 30 September 2023
HY24 / financial reportHalf Year Results Announcement - 30 September 2022
HY23 / financial reportResults Announcement 31 March 2023
FY23 / financial report2023 Annual Meeting - Presentation Slides
HY24 / commentaryRelated insights
Cross-company views selected from the metrics in this briefing.
Get the next General Capital briefing and related NZX reporting-season updates by email.